Sanders Morris Harris’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $203K | Sell |
1,578
-4,249
| -73% | -$497K | 0.12% | 65 |
|
|
2026
Q1 | $701K | Buy |
+5,827
| New | +$673K | 0.11% | 151 |
|
|
2025
Q4 | – | Sell |
-6,063
| Closed | -$509K | – | 198 |
|
|
2025
Q3 | $509K | Buy |
+6,063
| New | +$499K | 0.07% | 171 |
|
|
2025
Q2 | – | Sell |
-5,983
| Closed | -$526K | – | 246 |
|
|
2025
Q1 | $526K | Sell |
5,983
-83
| -1% | -$7.75K | 0.08% | 152 |
|
|
2024
Q4 | $604K | Hold |
6,066
| – | – | 0.09% | 150 |
|
|
2024
Q3 | $689K | Hold |
6,066
| – | – | 0.11% | 126 |
|
|
2024
Q2 | $751K | Hold |
6,066
| – | – | 0.12% | 117 |
|
|
2024
Q1 | $800K | Buy |
6,066
+1,549
| +34% | +$191K | 0.15% | 112 |
|
|
2023
Q4 | $528K | Sell |
4,517
-1,349
| -23% | -$140K | 0.26% | 105 |
|
|
2023
Q3 | $599K | Hold |
5,866
| – | – | 0.12% | 130 |
|
|
2023
Q2 | $673K | Buy |
+5,866
| New | +$666K | 0.15% | 108 |
|
|
2023
Q1 | – | Sell |
-5,544
| Closed | -$615K | – | 212 |
|
|
2022
Q4 | $615K | Hold |
5,544
| – | – | 0.23% | 99 |
|
|
2022
Q3 | $482K | Hold |
5,544
| – | – | 0.12% | 140 |
|
|
2022
Q2 | $510K | Hold |
5,544
| – | – | 0.11% | 144 |
|
|
2022
Q1 | $454K | Hold |
5,544
| – | – | 0.09% | 176 |
|
|
2021
Q4 | $424K | Hold |
5,544
| – | – | 0.07% | 190 |
|
|
2021
Q3 | $442K | Sell |
5,544
-16,000
| -74% | -$1.22M | 0.08% | 184 |
|
|
2021
Q2 | $1.68M | Sell |
21,544
-1,034
| -5% | -$76.9K | 0.33% | 64 |
|
|
2021
Q1 | $1.64M | Buy |
22,578
+549
| +2% | +$40.5K | 0.35% | 56 |
|
|
2020
Q4 | $1.73M | Hold |
22,029
| – | – | 0.39% | 52 |
|
|
2020
Q3 | $1.69M | Buy |
22,029
+19,242
| +690% | +$1.51M | 0.46% | 45 |
|
|
2020
Q2 | $207K | Sell |
2,787
-4,594
| -62% | -$346K | 0.1% | 110 |
|
|
2020
Q1 | $551K | Sell |
7,381
-511
| -6% | -$40.2K | 0.54% | 48 |
|
|
2019
Q4 | $680K | Buy |
7,892
+572
| +8% | +$47K | 0.15% | 139 |
|
|
2019
Q3 | $568K | Sell |
7,320
-524
| -7% | -$42K | 0.14% | 135 |
|
|
2019
Q2 | $633K | Buy |
+7,844
| New | +$601K | 0.16% | 125 |
|
|
2017
Q3 | – | Sell |
-4,271
| Closed | -$261K | – | 149 |
|
|
2017
Q2 | $261K | Sell |
4,271
-157
| -4% | -$9.56K | 0.11% | 98 |
|
|
2017
Q1 | $269K | Buy |
+4,428
| New | +$269K | 0.1% | 108 |
|
|
2016
Q3 | – | Sell |
-4,780
| Closed | -$262K | – | 201 |
|
|
2016
Q2 | $262K | Sell |
4,780
-22,181
| -82% | -$1.18M | 0.06% | 190 |
|
|
2016
Q1 | $1.35M | Buy |
+26,961
| New | +$1.32M | 0.23% | 98 |
|
Other funds holding MRK
ECSS
Sanders Morris Harris's MRK Position: Q2 2026 in Review
Sanders Morris Harris reduced its Merck (MRK) stake by 73% in Q2 2026, selling an estimated $497K and leaving 1,578 shares worth $203K. The position accounts for 0.12% of the portfolio, ranked #65.
Sanders Morris Harris first reported a position in MRK in Q1 2016 and has held it in 30 quarters since. The position peaked at $1.73M in Q4 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sanders Morris Harris held 1,578 shares of Merck worth $203K as of Q2 2026.
- Sanders Morris Harris sold 4,249 Merck shares in Q2 2026, an estimated $497K.
- Merck made up 0.12% of Sanders Morris Harris's portfolio in Q2 2026, its #65 holding.
- Sanders Morris Harris first reported a position in Merck in Q1 2016 and has held it in 30 quarters since.
- Sanders Morris Harris's Merck position peaked at $1.73M in Q4 2020.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.